Further, our data demonstrate that in CpG-induced MAS, the amount of IL-18 and IFNγ appeared to be uncoupled, such as inhibition of the NLRP3 inflammasome was sufficient to reduce plasma levels of IL-18, whilst levels of plasma IFNγ remained elevated. The gene discussed is NLRP3; the disease is macrophage activation syndrome.